Irma Febo to Humans
This is a "connection" page, showing publications Irma Febo has written about Humans.
Connection Strength
0.310
-
Vermund SH, Febo I. The Historic Elimination of Mother-to-Child HIV and Syphilis Transmission in Puerto Rico. P R Health Sci J. 2021 03; 40(1):3-5.
Score: 0.038
-
Carballo-Di?guez A, Giguere R, Bal?n IC, Dolezal C, Brown W, Lopez-Rios J, Sheinfil A, Frasca T, Rael C, Lentz C, Crespo R, Cruz Torres C, Leu CS, Febo I. Few Aggressive or Violent Incidents are Associated with the Use of HIV Self-tests to Screen Sexual Partners Among Key Populations. AIDS Behav. 2020 Jul; 24(7):2220-2226.
Score: 0.037
-
Carballo-Di?guez A, Giguere R, Bal?n IC, Brown W, Dolezal C, Leu CS, Lopez Rios J, Sheinfil AZ, Frasca T, Rael CT, Lentz C, Crespo R, Iribarren S, Cruz Torres C, Febo I. Use of Rapid HIV Self-Test to Screen Potential Sexual Partners: Results of the ISUM Study. AIDS Behav. 2020 Jun; 24(6):1929-1941.
Score: 0.036
-
Brooks KM, Pinilla M, Stek AM, Shapiro DE, Barr E, Febo IL, Paul ME, Deville JG, George K, Knowles K, Rungruengthanakit K, Browning R, Chakhtoura N, Capparelli EV, Mirochnick M, Best BM. Pharmacokinetics of Tenofovir Alafenamide With Boosted Protease Inhibitors in Pregnant and Postpartum Women Living With HIV: Results From IMPAACT P1026s. J Acquir Immune Defic Syndr. 2022 07 01; 90(3):343-350.
Score: 0.011
-
Momper JD, Wang J, Stek A, Shapiro DE, Scott GB, Paul ME, Febo IL, Burchett S, Smith E, Chakhtoura N, Denson K, Rungruengthanakit K, George K, Yang DZ, Capparelli EV, Mirochnick M, Best BM. Pharmacokinetics of darunavir and cobicistat in pregnant and postpartum women with HIV. AIDS. 2021 07 01; 35(8):1191-1199.
Score: 0.010
-
Brooks KM, Momper JD, Pinilla M, Stek AM, Barr E, Weinberg A, Deville JG, Febo IL, Cielo M, George K, Denson K, Rungruengthanakit K, Shapiro DE, Smith E, Chakhtoura N, Rooney JF, Haubrich R, Espina R, Capparelli EV, Mirochnick M, Best BM. Pharmacokinetics of tenofovir alafenamide with and without cobicistat in pregnant and postpartum women living with HIV. AIDS. 2021 03 01; 35(3):407-417.
Score: 0.010
-
Lentz C, Iribarren S, Giguere R, Conserve DF, Dolezal C, Lopez-Rios J, Bal?n IC, Sheinfil AZ, Rael CT, Brown W, Torres CC, Crespo R, Febo I, Carballo-Di?guez A. Broaching the Topic of HIV Self-testing with Potential Sexual Partners Among Men and Transgender Women Who Have Sex with Men in New York and Puerto Rico. AIDS Behav. 2020 Nov; 24(11):3033-3043.
Score: 0.009
-
Iribarren S, Lentz C, Sheinfil AZ, Giguere R, Lopez-Rios J, Dolezal C, Frasca T, Bal?n IC, Tagliaferri Rael C, Brown W, Cruz Torres C, Crespo R, Febo I, Carballo-Di?guez A. Using an HIV Self-test Kit to Test a Partner: Attitudes and Preferences Among High-Risk Populations. AIDS Behav. 2020 Nov; 24(11):3232-3243.
Score: 0.009
-
Sheinfil AZ, Giguere R, Dolezal C, Lopez-Rios J, Iribarren S, Brown W, Rael C, Lentz C, Bal?n I, Frasca T, Torres CC, Crespo R, Febo I, Carballo-Di?guez A. Information and Motivation Predict HIV-Serostatus Among a Population of High-Risk Men and Transgender Women Who Have Sex with Men. AIDS Behav. 2020 Oct; 24(10):2863-2871.
Score: 0.009
-
Dolezal C, Rael CT, Bal?n IC, Giguere R, Lentz C, Lopez-Rios J, Sheinfil AZ, Febo I, Carballo-Di?guez A. Substance Use and Testing Sexual Partners Using HIV Self-tests. AIDS Behav. 2020 Oct; 24(10):2856-2862.
Score: 0.009
-
Bal?n IC, Lopez-Rios J, Giguere R, Lentz C, Dolezal C, Cruz Torres C, Brown W, Crespo R, Sheinfil A, Tagliaferri Rael C, Febo I, Carballo-Di?guez A. Then We Looked at His Results: Men Who Have Sex With Men from New York City and Puerto Rico Report Their Sexual Partner's Reactions to Receiving Reactive HIV Self-Test Results. AIDS Behav. 2020 Sep; 24(9):2597-2605.
Score: 0.009
-
Rael CT, Giguere R, Lopez-Rios J, Lentz C, Bal?n IC, Sheinfil A, Dolezal C, Brown W, Frasca T, Torres CC, Crespo R, Iribarren S, Leu CS, Febo I, Carballo-Di?guez A. Transgender Women's Experiences Using a Home HIV-Testing Kit for Partner-Testing. AIDS Behav. 2020 Sep; 24(9):2732-2741.
Score: 0.009
-
Diaz C, Koren M, Lin L, Martinez LJ, Eckels KH, Campos M, Jarman RG, De La Barrera R, Lepine E, Febo I, Vaughn DW, Wilson TM, Paris RM, Schmidt AC, Thomas SJ. Safety and Immunogenicity of Different Formulations of a Tetravalent Dengue Purified Inactivated Vaccine in Healthy Adults from Puerto Rico: Final Results after 3 Years of Follow-Up from a Randomized, Placebo-Controlled Phase I Study. Am J Trop Med Hyg. 2020 05; 102(5):951-954.
Score: 0.009
-
Giguere R, Lopez-Rios J, Frasca T, Lentz C, Bal?n IC, Dolezal C, Rael CT, Brown W, Sheinfil AZ, Cruz Torres C, Crespo R, Febo I, Carballo-Di?guez A. Use of HIV Self-Testing Kits to Screen Clients Among Transgender Female Sex Workers in New York and Puerto Rico. AIDS Behav. 2020 Feb; 24(2):506-515.
Score: 0.009
-
Diaz C, Lin L, Martinez LJ, Eckels KH, Campos M, Jarman RG, De La Barrera R, Lepine E, Toussaint JF, Febo I, Innis BL, Thomas SJ, Schmidt AC. Phase I Randomized Study of a Tetravalent Dengue Purified Inactivated Vaccine in Healthy Adults from Puerto Rico. Am J Trop Med Hyg. 2018 05; 98(5):1435-1443.
Score: 0.008
-
Bauermeister J, Giguere R, Leu CS, Febo I, Cranston R, Mayer K, Carballo-Di?guez A. Interactive Voice Response System: Data Considerations and Lessons Learned During a Rectal Microbicide Placebo Adherence Trial for Young Men Who Have Sex With Men. J Med Internet Res. 2017 06 09; 19(6):e207.
Score: 0.007
-
Giguere R, Frasca T, Dolezal C, Febo I, Cranston RD, Mayer K, McGowan I, Carballo-Di?guez A. Acceptability of Three Novel HIV Prevention Methods Among Young Male and Transgender Female Sex Workers in Puerto Rico. AIDS Behav. 2016 10; 20(10):2192-2202.
Score: 0.007
-
Romas L, Birse K, Mayer KH, Abou M, Westmacott G, Giguere R, Febo I, Cranston RD, Carballo-Di?guez A, McGowan I, Burgener A. Rectal 1% Tenofovir Gel Use Associates with Altered Epidermal Protein Expression. AIDS Res Hum Retroviruses. 2016 Oct/Nov; 32(10-11):1005-1015.
Score: 0.007
-
McGowan I, Cranston RD, Mayer KH, Febo I, Duffill K, Siegel A, Engstrom JC, Nikiforov A, Park SY, Brand RM, Jacobson C, Giguere R, Dolezal C, Frasca T, Leu CS, Schwartz JL, Carballo-Di?guez A. Project Gel a Randomized Rectal Microbicide Safety and Acceptability Study in Young Men and Transgender Women. PLoS One. 2016; 11(6):e0158310.
Score: 0.007
-
Frasca T, Giguere R, Ibitoye M, Dolezal C, Febo I, Cranston RD, Mayer K, McGowan I, Carballo-Di?guez A. Lessons for Rectal Microbicide Development From an Acceptability Trial of a Placebo Gel Applied Prior to Receptive Anal Intercourse. Arch Sex Behav. 2017 May; 46(4):1101-1109.
Score: 0.007
-
Silva-Su?rez G, Bastida E, Rabionet SE, Beck-Sagu? C, Febo I, Zorrilla CD. "That's True Love:" Lived Experiences of Puerto Rican Perinatally HIV-Infected Youth within Their Families' Context. Int J Environ Res Public Health. 2015 Dec 22; 13(1):ijerph13010007.
Score: 0.007
-
Dolezal C, Frasca T, Giguere R, Ibitoye M, Cranston RD, Febo I, Mayer KH, McGowan I, Carballo-Di?guez A. Awareness of Post-Exposure Prophylaxis (PEP) and Pre-Exposure Prophylaxis (PrEP) Is Low but Interest Is High Among Men Engaging in Condomless Anal Sex With Men in Boston, Pittsburgh, and San Juan. AIDS Educ Prev. 2015 Aug; 27(4):289-97.
Score: 0.007
-
Giguere R, Dolezal C, Bauermeister JA, Frasca T, Valladares J, Febo I, Cranston RD, Mayer K, McGowan I, Carballo-Di?guez A. Influence of Partner Type on Acceptability and Likelihood of Use of a Rectal Microbicide Among Young Men Who Have Sex With Men in the United States and Puerto Rico. J Sex Res. 2016 Jul-Aug; 53(6):633-41.
Score: 0.006
-
Boyer CB, Robles-Schrader GM, Li SX, Miller RL, Korelitz J, Price GN, Rivera Torres CM, Chutuape KS, Stines SJ, Straub DM, Peralta L, Febo I, Hightow-Weidman L, Gonin R, Kapogiannis BG, Ellen JM. A comparison of network-based strategies for screening at-risk Hispanic/Latino adolescents and young adults for undiagnosed asymptomatic HIV infection. J Adolesc Health. 2014 Dec; 55(6):765-73.
Score: 0.006
-
Carballo-Di?guez A, Giguere R, Dolezal C, Bauermeister J, Leu CS, Valladares J, Frasca T, Labbett R, Cranston RD, Febo I, Mayer K, McGowan I. Adherence to rectal gel use among mainly ethnic minority young men who have sex with men during a 3-month placebo gel trial: implications for microbicide research. AIDS Behav. 2014 Sep; 18(9):1726-33.
Score: 0.006
-
Carballo-Di?guez A, Giguere R, Dolezal C, Bauermeister J, Leu CS, Valladares J, Rohan LC, Anton PA, Cranston RD, Febo I, Mayer K, McGowan I. Rectal-specific microbicide applicator: evaluation and comparison with a vaginal applicator used rectally. AIDS Behav. 2014 Sep; 18(9):1734-45.
Score: 0.006
-
McGowan I, Gomez K, Bruder K, Febo I, Chen BA, Richardson BA, Husnik M, Livant E, Price C, Jacobson C. Phase 1 randomized trial of the vaginal safety and acceptability of SPL7013 gel (VivaGel) in sexually active young women (MTN-004). AIDS. 2011 May 15; 25(8):1057-64.
Score: 0.005
-
Zorrilla CD, Tamayo Agrait V, Febo I, Santiago LE, D?az C, Salabarr?a I, P?rez E, Hillyer GV. Reduction in the perinatal HIV transmission: the experience at the Maternal Infant Studies Center and Gamma Projects at the University of Puerto Rico School of Medicine. P R Health Sci J. 2007 Dec; 26(4):329-35.
Score: 0.004
-
Blasini I, Chantry C, Cruz C, Ortiz L, Salabarr?a I, Scalley N, Matos B, Febo I, D?az C. Disclosure model for pediatric patients living with HIV in Puerto Rico: design, implementation, and evaluation. J Dev Behav Pediatr. 2004 Jun; 25(3):181-9.
Score: 0.003
-
Hillyer GV, Febo I, D?az C. The rapid diagnosis of HIV-1 infection in mothers in Puerto Rico: a crucial testing strategy for maximal reduction of perinatal transmission. P R Health Sci J. 2002 Jun; 21(2):133-5.
Score: 0.003